Cardiovascular disease is a dubious disease in the field of blood tumors, with complex clinical outcomes that often involve multi-system congestion. Early identification and standardised clinical care are essential for improving prognosis. Diagnosis of this disease requires a combination of clinical outcomes, imaging inspections, laboratory tests and pathological activation.
Platforms can assist in linking teams of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. Individual development of treatment programs for treatment and management of cardiovascular disease, usually including drug therapy, rehabilitation prevention, and regular follow-up, is required. In recent years, with the development of treatment-oriented, immune-regulatory therapy and precision medicine, many blood tumor diseases that were previously difficult to treat have been significantly improved.
Treatment needs to be closely monitored for efficacy and adverse reactions, adjusted in time according to changes in the disease. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of cardiovascular cancers. 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment programs; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.